No Data
No Data
JonesTrading Initiates Editas Medicine(EDIT.US) With Buy Rating, Announces Target Price $13
Editas Medicine, Inc. (EDIT) Presents at Morgan Stanley 22nd Annual Global Healthcare Conference (Transcript)
Editas Medicine to Participate in Upcoming Investor Conferences
Editas Medicine, Inc. (NASDAQ:EDIT) Looks Inexpensive After Falling 32% But Perhaps Not Attractive Enough
We're Keeping An Eye On Editas Medicine's (NASDAQ:EDIT) Cash Burn Rate
Editas Medicine, Inc. (NASDAQ:EDIT) Analysts Are Cutting Their Estimates: Here's What You Need To Know
No Data
No Data